265 related articles for article (PubMed ID: 29773162)
1. Psychopharmacology and Cardiovascular Disease.
Piña IL; Di Palo KE; Ventura HO
J Am Coll Cardiol; 2018 May; 71(20):2346-2359. PubMed ID: 29773162
[TBL] [Abstract][Full Text] [Related]
2. Avoiding psychotropic drug interactions in the cardiovascular patient.
DeVane CL; Markowitz JS
Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular medications.
Williams S; Wynn G; Cozza K; Sandson NB
Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
[No Abstract] [Full Text] [Related]
4. Heart and mind: (2) psychotropic and cardiovascular therapeutics.
Shah SU; Iqbal Z; White A; White S
Postgrad Med J; 2005 Jan; 81(951):33-40. PubMed ID: 15640426
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology.
Catterson ML; Preskorn SH; Martin RL
Psychiatr Clin North Am; 1997 Mar; 20(1):205-18. PubMed ID: 9139291
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacology in psychodermatology.
Shukla R; Sasseville D
J Cutan Med Surg; 2008; 12(6):255-67. PubMed ID: 19317947
[TBL] [Abstract][Full Text] [Related]
7. Clinical psychopharmacology and the elderly patient.
Salzman C; Shader RI; Van der Kolk BA
N Y State J Med; 1976 Jan; 76(1):71-7. PubMed ID: 1060928
[No Abstract] [Full Text] [Related]
8. Psychopharmacology.
Thronson LR; Pagalilauan GL
Med Clin North Am; 2014 Sep; 98(5):927-58. PubMed ID: 25134867
[TBL] [Abstract][Full Text] [Related]
9. Child and adolescent psychopharmacology. Important developmental issues.
Tosyali MC; Greenhill LL
Pediatr Clin North Am; 1998 Oct; 45(5):1021-35, vii. PubMed ID: 9884673
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular side effects of psychopharmacologic therapy.
Potočnjak I; Degoricija V; Vukičević Baudoin D; Čulig J; Jakovljević M
Int J Cardiol; 2016 Sep; 219():367-72. PubMed ID: 27352209
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacology.
Sekhon S; Kroumpouzos G; Koo J
G Ital Dermatol Venereol; 2018 Aug; 153(4):549-556. PubMed ID: 29667795
[TBL] [Abstract][Full Text] [Related]
12. Drug interactions in psychopharmacology.
Callahan AM; Fava M; Rosenbaum JF
Psychiatr Clin North Am; 1993 Sep; 16(3):647-71. PubMed ID: 8415238
[TBL] [Abstract][Full Text] [Related]
13. Potential drug-drug interactions on a tertiary-care hospital consultation-liaison psychiatry service.
Adson DE; Crow SJ; Meller WH; Magraw RM
Psychosomatics; 1998; 39(4):360-5. PubMed ID: 9691705
[TBL] [Abstract][Full Text] [Related]
14. Challenges in pharmacologic management of the hospitalized patient with psychiatric comorbidity.
Ward M; Schwartz A
J Hosp Med; 2013 Sep; 8(9):523-9. PubMed ID: 23913579
[TBL] [Abstract][Full Text] [Related]
15. At long last, long-lasting psychiatric medications: an overview of controlled-release technologies.
Stahl SM
J Clin Psychiatry; 2003 Apr; 64(4):355-6. PubMed ID: 12716234
[No Abstract] [Full Text] [Related]
16. [Combinations and interactions in psychopharmacology].
Lépine JP; Lemoine JM
Soins Psychiatr; 1981 Jan; (7):43-6. PubMed ID: 6911846
[No Abstract] [Full Text] [Related]
17. Metabolism and chirality in psychopharmacology.
Baker GB; Coutts RT; Holt A
Biol Psychiatry; 1994 Aug; 36(4):211-3. PubMed ID: 7986884
[No Abstract] [Full Text] [Related]
18. Use of psychotropic drugs in the dermatology patient: When to start and stop?
Shah B; Levenson JL
Clin Dermatol; 2018; 36(6):748-755. PubMed ID: 30446199
[TBL] [Abstract][Full Text] [Related]
19. Update on geriatric psychopharmacology.
Salzman C
Geriatrics; 1979 Aug; 34(8):87-90. PubMed ID: 447090
[No Abstract] [Full Text] [Related]
20. Drug glucuronidation in clinical psychopharmacology.
Liston HL; Markowitz JS; DeVane CL
J Clin Psychopharmacol; 2001 Oct; 21(5):500-15. PubMed ID: 11593076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
